Recommended Acute Migraine Cocktail
For an adult with episodic migraine and no contraindications to vasoconstrictors, the recommended acute migraine cocktail is a triptan combined with an NSAID (or acetaminophen if NSAIDs are contraindicated), initiated as early as possible after headache onset. 1
Specific Medication Combinations
The most evidence-supported combinations include:
- Sumatriptan + Naproxen sodium (strongest evidence for combination therapy) 1, 2
- Any triptan (eletriptan, rizatriptan, zolmitriptan, almotriptan, frovatriptan, naratriptan) + any NSAID (ibuprofen, naproxen, diclofenac, aspirin) 1
- Triptan + acetaminophen (when NSAIDs contraindicated or not tolerated) 1
Treatment Algorithm
Step 1: Initial Assessment
Start with combination therapy immediately if the patient has:
- Moderate to severe migraine attacks
- History of inadequate response to NSAIDs or acetaminophen alone
- Desire for rapid, complete pain relief 1
Step 2: Add Antiemetic if Needed
Add a nonoral triptan formulation plus antiemetic for patients with:
- Severe nausea or vomiting
- Rapid progression to peak intensity 1
Step 3: Route Selection
Choose formulation based on:
- Oral: Standard first-line for most patients
- Nasal spray: Faster onset, useful with mild nausea
- Subcutaneous: Fastest onset, highest efficacy for severe attacks 1, 3
Critical Implementation Points
Timing is essential: Counsel patients to treat at headache onset, not after pain becomes severe. Early combination therapy improves efficacy significantly. 1
Dosing specifics:
- Ensure adequate dosing of both components
- Do not exceed maximum daily doses
- Common effective doses: sumatriptan 50-100mg + naproxen 500mg 1, 4
Important Caveats
Medication Overuse Risk
Limit triptan use to <10 days per month and NSAIDs to <15 days per month to prevent medication overuse headache. 1
What NOT to Use
Avoid opioids and butalbital - these are explicitly not recommended for acute episodic migraine treatment due to poor efficacy and high risk of medication overuse headache. 1
If Combination Therapy Fails
Second-line options for refractory cases include:
- CGRP antagonists (gepants: rimegepant, ubrogepant, zavegepant) 1
- Dihydroergotamine 1
- Lasmiditan (only after all other options exhausted) 1
Special Populations
Pregnancy/lactation: Acetaminophen is safest; sumatriptan may be considered in selected cases and is compatible with breastfeeding. 1, 5
Cardiovascular risk: Since this patient has no contraindications to vasoconstrictors, triptans are appropriate. For patients with cardiovascular disease, gepants or lasmiditan would be preferred alternatives. 6
The 2025 American College of Physicians guideline represents the most current, high-quality evidence and strongly supports this combination approach over monotherapy for optimal pain freedom and sustained relief. 1